Original Query: ALL
Previous Study | Return to List | Next Study

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01349049
Recruitment Status : Active, not recruiting
First Posted : May 6, 2011
Last Update Posted : February 1, 2018
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2018
  Estimated Study Completion Date : March 2018